Log In
BCIQ
Print this Print this
 

KN203 (formerly GRT203)

  Manage Alerts
Collapse Summary General Information
Company Gruenenthal Group
DescriptionMu opioid receptor (MOR) agonist
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationIncontinence
Indication DetailsTreat urinary incontinence
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today